Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium. - Wikidata - wikimedia - TriplyDB

Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium.

Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium.

http://www.wikidata.org/entity/Q34243574

about

Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease β(2) -adrenoceptor agonists: current and future direction Safety and efficacy of 12-week or longer indacaterol treatment in moderate-to-severe COPD patients: a systematic review.Indacaterol on dyspnea in chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized placebo-controlled trials.V0162 a new long-acting bronchodilator for treatment of chronic obstructive lung diseases: preclinical and clinical results Effects of indacaterol versus tiotropium on respiratory mechanics assessed by the forced oscillation technique in patients with chronic obstructive pulmonary disease.Indacaterol (arcapta neohaler) for chronic obstructive pulmonary disease Indacaterol in chronic obstructive pulmonary disease: an update for clinicians.A UK-based cost-utility analysis of indacaterol, a once-daily maintenance bronchodilator for patients with COPD, using real world evidence on resource use.Dual Bronchodilator Therapy with Umeclidinium/Vilanterol Versus Tiotropium plus Indacaterol in Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial.Indacaterol: a comprehensive review.Chronic obstructive pulmonary disease in China: the potential role of indacaterol Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.Effects of indacaterol versus tiotropium on exercise tolerance in patients with moderate COPD: a pilot randomized crossover study.Efficacy of indacaterol on quality of life and pulmonary function in patients with COPD and inhaler device preferences.Efficacy and safety of coadministration of once-daily indacaterol and glycopyrronium versus indacaterol alone in COPD patients: the GLOW6 study.An update on the use of indacaterol in patients with COPD.Profiling the bronchodilator effects of the novel ultra-long-acting β2-agonist indacaterol against established treatments in chronic obstructive pulmonary disease.Long-acting β-adrenoceptor agonists in the management of COPD: focus on indacaterol.Optimum bronchodilator combinations in chronic obstructive pulmonary disease: what is the current evidence?Indacaterol: a review of its use as maintenance therapy in patients with chronic obstructive pulmonary disease.Indacaterol: a new long-acting β2-agonist in the management of chronic obstructive pulmonary disease.Indacaterol: a novel long-acting β(2) -agonist.Future of chronic obstructive pulmonary disease management.A review of the advances in chronic obstructive pulmonary disease treatment.Indacaterol 75 μg once daily for the treatment of patients with chronic obstructive pulmonary disease: a North American perspective.Role of indacaterol and the newer very long-acting β2-agonists in patients with stable COPD: a review Turning a molecule into a medicine: the development of indacaterol as a novel once-daily bronchodilator treatment for patients with COPD.Combination therapy with indacaterol and glycopyrronium bromide in the management of COPD: an update on the evidence for efficacy and safety.Bronchoprotective tolerance with indacaterol is not modified by concomitant tiotropium in persistent asthma.Lung Delivery of Indacaterol and Mometasone Furoate Following Inhalation of QMF149 in Healthy Volunteers.The role of indacaterol for chronic obstructive pulmonary disease (COPD).Clinical trial design in chronic obstructive pulmonary disease: current perspectives and considerations with regard to blinding of tiotropium.Clinical trial simulation to assist in COPD trial planning and design with a biomarker-based diagnostic: when to pull the trigger?Computed tomography assessment of airway dimensions with combined tiotropium and indacaterol therapy in COPD patients.FLIGHT1 and FLIGHT2: Efficacy and Safety of QVA149 (Indacaterol/Glycopyrrolate) versus Its Monocomponents and Placebo in Patients with Chronic Obstructive Pulmonary Disease.Collection, synthesis, and interpretation of evidence: a proof-of-concept study in COPD.

P2860

Q24200476-56867858-3DAB-4C5E-A6E6-E5C2DB21F52A Q24604047-ECAE95B7-1A47-4406-8D4C-FDDBF48B38DF Q34544020-33E764FF-BCF2-4A62-A0B8-8B36A8590342 Q34686851-5813F537-4EDD-40A4-9D5B-DEEDAB23E06E Q35710238-051F9CD6-C6AC-4859-856F-45B515B303C9 Q35766357-95FEE366-92D7-4E64-95DB-2D68D19C5ECA Q35958673-55F6D59A-B2C9-4629-8867-536BC6C297E4 Q36443777-8D237953-4A19-4F38-BF2C-F05DE82CC356 Q36875110-59535A28-4AE8-4B71-BC30-50C8197517E7 Q36924015-AF75BC91-6CFB-409F-9261-A4C6D6AC743B Q37057061-F058E4B6-2BE1-4DDF-A2D0-1EF062C83C2E Q37128034-36FE523F-2FC4-45F9-8390-BDC3651E5E16 Q37177278-51A1221B-36A6-4ED7-999A-3FE07824F313 Q37392356-6E71ED6F-41DE-433D-B8C3-B1E4ED799BAD Q37524951-61ADCBB0-82C2-437B-8486-783ECE1403B3 Q37614103-FB6244F1-58DE-4902-ABDC-535A4460C7B5 Q37808058-BCD36055-4A05-4191-AD04-EDE12B8D3B4D Q37896372-72110276-C73A-42DB-8300-5DC47CD9FFB7 Q37911291-C9E4E116-4A7E-4AE8-A0B5-C9A2808E4327 Q37982432-23F3F7EF-7871-4D01-879A-1904AAAFE16E Q37987211-DDC54274-E7B4-4384-9A20-7F098E55D154 Q37999465-425A46AD-6076-449B-94B6-827176A52641 Q38002357-010814B9-0BB0-4FDD-A40C-AF55B5F3151B Q38025725-7DD467FA-FF5F-4FE9-98F9-194CC01AD19F Q38053126-AA8C9DF6-42BD-4FEF-9FAB-0AA593B6AF5C Q38072277-CBD39BE1-7016-4351-99EA-DA6C7D6D5409 Q38148145-219DDD7B-BAB0-43E6-A1F5-A1064DE306F9 Q38248438-E5E073A7-EC4E-4A5B-B3F1-B17E642A96D3 Q38359553-05709669-1CFD-4C1A-A8BB-D99E68DD602E Q38700260-84B3D12C-A692-4FE7-B160-BAAC7BAAF5C7 Q39678636-AB5A418C-871D-43C2-AEEF-C5F1C8180419 Q41853545-AB1A9FBD-6689-4B0A-8262-A3F4871E406D Q42533804-0E35ECB6-E079-474F-AC15-B1D3AF20156A Q43554429-86056C9C-9524-4264-8AEA-558822E98398 Q48080686-A1400107-B43F-4B96-A7E7-CE240660DF48 Q50954570-00737C29-4A73-4F2D-B03F-2AC02630038B Q51278385-BD3A13F2-B9F0-4CFB-97AB-F3461435D3E1

P2860

Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium.

http://www.wikidata.org/entity/Q34243574

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Indacaterol provides 24-hour b ...... ed comparison with tiotropium.

@ast

Indacaterol provides 24-hour b ...... ed comparison with tiotropium.

@en

Indacaterol provides 24-hour b ...... ed comparison with tiotropium.

@nl

type

label

Indacaterol provides 24-hour b ...... ed comparison with tiotropium.

@ast

Indacaterol provides 24-hour b ...... ed comparison with tiotropium.

@en

Indacaterol provides 24-hour b ...... ed comparison with tiotropium.

@nl

prefLabel

Indacaterol provides 24-hour b ...... ed comparison with tiotropium.

@ast

Indacaterol provides 24-hour b ...... ed comparison with tiotropium.

@en

Indacaterol provides 24-hour b ...... ed comparison with tiotropium.

@nl

P1433

Q34243574-CC380E8C-3AEC-4AD6-AE31-2E9D0C1FB2EA

P1476

Q34243574-3C4F5FE4-6C3F-4D32-A3BB-F2903D3F85E3

P2093

Q34243574-32FCDFBF-0156-4A3D-BB29-D65946D671FA

Q34243574-48360B34-7986-4461-9963-889E6CD29107

Q34243574-8C419313-5BFF-46C9-8BFD-80080C2FCB8C

Q34243574-9BC3B3DC-C17B-46F4-BA56-319B2CE92594

Q34243574-9E728B07-EF49-4B0C-8B96-15CD2DCA7969

Q34243574-D567635B-7208-444A-BAA8-0278708EC8E0

P2860

Q34243574-198680B8-4555-4CDD-8839-E6877340B7FD

Q34243574-1A37565A-A1A2-46B1-A1F5-CEDF18D6C083

Q34243574-39AD06E9-9CD9-43F3-97F6-5A49AECF1011

Q34243574-522030A6-16EE-42E5-9B08-107356FE6C11

Q34243574-691C26E6-A080-4142-B436-C4DF44434E03

Q34243574-713E438A-51A6-4E69-AC57-67CE38245966

Q34243574-7AFB33B5-6F8F-4297-9226-C623394BC311

Q34243574-82208E31-6D6D-401D-B94F-DD2007149EB0

Q34243574-A3A8CDC8-5D47-4C4E-A9FC-03E48F40C8F9

Q34243574-B1BEB48B-E7DC-4DE8-A905-4FE8E8C1BF09

P2888

Q34243574-D55996F8-11C0-4321-8758-7A3A360D5A17

P304

Q34243574-CFC2B5B8-847A-4249-9E8F-F4D894558773

P31

Q34243574-F219A27B-32CA-4A40-80B3-C2D8EAA8E5E2

P356

Q34243574-32E168AE-DADD-496C-AB8C-4EC3A9BD94BD

P478

Q34243574-6FB346C3-5547-4080-B6CE-84EAFA94AC0B

P50

Q34243574-536D66E2-D805-4FB1-9BD1-DA2FC301F157

Q34243574-CE46AE2D-367E-483F-B8A5-31E7BA795633

P577

Q34243574-9749575A-EF0B-4CE7-B7F1-8EE57ECC298C

P5875

Q34243574-4A6B9F9E-9220-4D95-B9F9-BFDB02049F2F

P6179

Q34243574-CDFE551A-D73D-40CD-8FDA-6D4F3D68E401

P698

Q34243574-E361844B-6F38-42B3-935D-F5D2DC7EEE76

P921

Q34243574-B25C41EE-0D7D-472B-94FA-C21967E8F328

P932

Q34243574-C6F603B0-EC2A-46F2-873E-F5E4893A0173

P356

1465-9921-11-135

P1433

Respiratory Research

P1476

Indacaterol provides 24-hour b ...... ded comparison with tiotropium

@en

P2093

Benjamin Kramer

http://www.w3.org/2001/XMLSchema#string

Damon Jack

http://www.w3.org/2001/XMLSchema#string

INTIME study investigators (INdacaterol & TIotropium: Measuring Efficacy)

http://www.w3.org/2001/XMLSchema#string

Mark Higgins

http://www.w3.org/2001/XMLSchema#string

Roger Owen

http://www.w3.org/2001/XMLSchema#string

Simon Piggott

http://www.w3.org/2001/XMLSchema#string

P2860

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

Tiotropium for stable chronic obstructive pulmonary disease

Ultra long-acting beta 2-agonists in development for asthma and chronic obstructive pulmonary disease

Standardisation of spirometry

A systematic review of the associations between dose regimens and medication compliance.

Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease.

Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD.

Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD

Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease.

Minimal clinically important differences in COPD lung function.

P2888

1465-9921-11-135

P304

135

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1465-9921-11-135

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

David Ramos-Barbón

Claus Vogelmeier

P577

2010-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47335580

http://www.w3.org/2001/XMLSchema#string

P6179

1053059746

http://www.w3.org/2001/XMLSchema#string

P698

20920365

http://www.w3.org/2001/XMLSchema#string

P921

P932

2964613

http://www.w3.org/2001/XMLSchema#string